13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, Diabetes Canada Clinical Practice Guidelines and the American Diabetes Association emphasize a food plan of at least 175 g/day of carbohydrates distributed across several meals, without specifying calorie limits [10,58].”
From Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives (2025) · cites this paper as [10]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Weight Gain During Pregnancy: Reexamining the Guidelines
Rasmussen, K. M., & Yaktine, A. L. (2009) · Cited by 4,473
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
Duckitt, K., & Harrington, D. (2005) · BMJ · doi:10.1136/bmj.38380.674340.e0 · Cited by 1,784 · cited 1×
“Diabetes in pregnancy is associated with an increased risk of preeclampsia (47).”
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291 · cited 2×
“port the efficacy and short-term safety of metformin (30,31) and glyburide (32) for the treatment of GDM, both agents”
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“port the efficacy and short-term safety of metformin (30,31) and glyburide (32) for the treatment of GDM, both agents”
Ratner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0772 · Cited by 867
Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study
Villamor, E., & Cnattingius, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69473-7 · Cited by 756
Less-Tight versus Tight Control of Hypertension in Pregnancy
Magee, L. A., von Dadelszen, P., Rey, E., Ross, S., Asztalos, E., Murphy, K. E., Menzies, J., Sanchez, J., Singer, J., Gafni, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404595 · Cited by 672
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331901 · Cited by 666
Practice Bulletin No. 137: Gestational Diabetes Mellitus
(2013) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000433006.09219.f1 · Cited by 581
Duration of Lactation and Incidence of Type 2 Diabetes
Stuebe, A. M. (2005) · JAMA · doi:10.1001/jama.294.20.2601 · Cited by 505
Henderson, J. T., Whitlock, E. P., O’Connor, E., Senger, C. A., Thompson, J. H., & Rowland, M. G. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2844 · Cited by 499
Balsells, M., Garcia-Patterson, A., Sola, I., Roque, M., Gich, I., & Corcoy, R. (2015) · BMJ · doi:10.1136/bmj.h102 · Cited by 498
Aroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
Wang, C., Wei, Y., Zhang, X., Zhang, Y., Xu, Q., Sun, Y., Su, S., Zhang, L., Liu, C., Feng, Y., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.037 · Cited by 416
Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study
Jovanovic-Peterson, L., Peterson, C. M., Reed, G. F., Metzger, B. E., Mills, J. L., Knopp, R. H., & Aarons, J. H. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90637-7 · Cited by 411
Metabolic Control and Progression of Retinopathy: The Diabetes in Early Pregnancy Study
Chew, E. Y., Mills, J. L., Metzger, B. E., Remaley, N. A., Jovanovic-Peterson, L., Knopp, R. H., Conley, M., Rand, L., Simpson, J. L., Holmes, L. B., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.631 · Cited by 402
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00661 · Cited by 395
Treatment of hypertension in pregnant women
Sibai, B. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350407 · Cited by 366
Bullo, M., Tschumi, S., Bucher, B. S., Bianchetti, M. G., & Simonetti, G. D. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196352 · Cited by 334 · cited 2×
“During pregnancy, treatment with ACE inhibitors and angiotensin receptor blockers is contraindicated because they may cause fetal renal dysplasia, oligohydramnios, and intrauterine growth restriction (8).”
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Poor pregnancy outcome in women with type 2 diabetes
Clausen, T. D., Mathiesen, E., Ekbom, P., Hellmuth, E., Mandrup-Poulsen, T., & Damm, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.323 · Cited by 318 · cited 1×
“third trimester in women with type 2 diabetes compared with the first trimester in women with type 1 diabetes (52,53).”
Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0853 · Cited by 315 · cited 1×
“Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in women with polycystic ovary syndrome havenot demonstratedbenefit in preventing spontaneous abortion or GDM (42), and there is no evidence-based need to continuemetformin in such patients once”
Suhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302
Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0110 · Cited by 279
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Placental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Statins and congenital malformations: cohort study
Bateman, B. T., Hernandez-Diaz, S., Fischer, M. A., Seely, E. W., Ecker, J. L., Franklin, J. M., Desai, R. J., Allen-Coleman, C., Mogun, H., Avorn, J., et al. (2015) · BMJ · doi:10.1136/bmj.h1035 · Cited by 236
Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P. (2009) · Diabetes Care · doi:10.2337/dc08-2061 · Cited by 227
Metformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222 · cited 1×
“port the efficacy and short-term safety of metformin (30,31) and glyburide (32) for the treatment of GDM, both agents”
Tobias, D. K., Hu, F. B., Chavarro, J., Rosner, B., Mozaffarian, D., & Zhang, C. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3747 · Cited by 219
Guerin, A., Nisenbaum, R., & Ray, J. G. (2007) · Diabetes Care · doi:10.2337/dc07-0278 · Cited by 215
Population pharmacokinetics of metformin in late pregnancy
Charles, B., Norris, R., Xiao, X., & Hague, W. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000184161.52573.0e · Cited by 212
Holmes, V. A., Young, I. S., Patterson, C. C., Pearson, D. W. M., Walker, J. D., Maresh, M. J. A., McCance, D. R., & for the Diabetes and Pre-eclampsia Intervention Trial Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0244 · Cited by 205
Farrar, D., Tuffnell, D. J., West, J., & West, H. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005542.pub3 · Cited by 194
Diet and exercise interventions for preventing gestational diabetes mellitus
Bain, E., Crane, M., Tieu, J., Han, S., Crowther, C. A., & Middleton, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010443.pub2 · Cited by 188
Viana, L. V., Gross, J. L., & Azevedo, M. J. (2014) · Diabetes Care · doi:10.2337/dc14-1530 · Cited by 187 · cited 1×
“Medical Nutrition Therapy Medical nutrition therapy for GDM is an individualized nutrition plan developed between the woman and a registered dietitian familiar with the management of GDM (27,28).”
Camelo Castillo, W., Boggess, K., Stürmer, T., Brookhart, M. A., Benjamin, D. K., & Jonsson Funk, M. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.74 · Cited by 177
Palomba, S., Orio, F., Nardo, L. G., Falbo, A., Russo, T., Corea, D., Doldo, P., Lombardi, G., Tolino, A., Colao, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0689 · Cited by 177
Different types of dietary advice for women with gestational diabetes mellitus
Han, S., Middleton, P., Shepherd, E., Van Ryswyk, E., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009275.pub3 · Cited by 177
Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes
Maresh, M. J. A., Holmes, V. A., Patterson, C. C., Young, I. S., Pearson, D. W. M., Walker, J. D., & McCance, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-1755 · Cited by 175
Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study
Mosca, A., Paleari, R., Dalfrà, M. G., Di Cianni, G., Cuccuru, I., Pellegrini, G., Malloggi, L., Bonomo, M., Granata, S., Ceriotti, F., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.064899 · Cited by 161
Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes
Taguchi, N., Rubin, E. T., Hosokawa, A., Choi, J., Ying, A. Y., Moretti, M. E., Koren, G., & Ito, S. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.06.009 · Cited by 142 · cited 1×
“, ACE inhibitors (8), angiotensin receptor blockers (8), and statins (9,10); and referral for a comprehensive eye exam.”
HbA1c in Early Diabetic Pregnancy and Pregnancy Outcomes
Nielsen, G. L., Møller, M., & Sørensen, H. T. (2006) · Diabetes Care · doi:10.2337/dc06-0914 · Cited by 140
Peterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.09.009 · Cited by 130
Jiang, Y.-F., Chen, X.-Y., Ding, T., Wang, X.-F., Zhu, Z.-N., & Su, S.-W. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4403 · Cited by 124
Mayo, K., Melamed, N., Vandenberghe, H., & Berger, H. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.08.027 · Cited by 122 · cited 2×
“and Pregnancy Study Groups (IADPSG) (25) diagnostic thresholds are used.”
InfluentialNachum, Z., Zafran, N., Salim, R., Hissin, N., Hasanein, J., Gam Ze Letova, Y., Suleiman, A., & Yefet, E. (2017) · Diabetes Care · doi:10.2337/dc16-2307 · Cited by 118
Motherisk Rounds: Risks of Statin Use During Pregnancy: A Systematic Review
Kazmin, A., Garcia-Bournissen, F., & Koren, G. (2007) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32656-1 · Cited by 117
Manderson, J. G., Patterson, C., Hadden, D. R., Traub, A. I., Ennis, C. N., & McCance, D. R. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00497-6 · Cited by 114
Werner, E. F., Hauspurg, A. K., & Rouse, D. J. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001115 · Cited by 113
Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes
Brown, J., Martis, R., Hughes, B., Rowan, J., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011967.pub2 · Cited by 95
Differing causes of pregnancy loss in type 1 and type 2 diabetes
Cundy, T., Gamble, G., Neale, L., Elder, R., McPherson, P., Henley, P., & Rowan, J. (2007) · Diabetes Care · doi:10.2337/dc07-0555 · Cited by 90
Pereira, P. F., Alfenas, R. D. C. G., & Araújo, R. M. A. (2014) · Jornal de Pediatria · doi:10.1016/j.jped.2013.02.024 · Cited by 89
Charron-Prochownik, D., Sereika, S. M., Becker, D., White, N. H., Schmitt, P., Powell, A. B., Diaz, A. M., Jones, J., Herman, W. H., Rodgers Fischl, A. F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0355 · Cited by 89
Different types of dietary advice for women with gestational diabetes mellitus
Han, S., Crowther, C. A., Middleton, P., & Heatley, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009275.pub2 · Cited by 72
Carbohydrate Metabolism in Pregnancy and the Newborn · IV
(1989) · doi:10.1007/978-1-4471-1680-6 · Cited by 41
Figueroa, H. M., Schuster, M., Maggio, L., Pedroza, C., Chauhan, S. P., & Paglia, M. J. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002101 · Cited by 30
Koivusalo, S. B., Rono, K., Klemetti, M. M., Roine, R. P., Lindstrom, J., Erkkola, M., Kaaja, R. J., Pöyhönen‐Alho, M., Tiitinen, A., Huvinen, E., et al. (2016) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 30
Bullo, M., Tschumi, S., Bucher, B. S., Bianchetti, M. G., & Simonetti, G. D. (2012) · BORIS (University Library Bern) · Cited by 28
Research works printed but not linked: 3
- Charron-Prochownik, 2016, Diabetes and Reproductive Health for Girls
- Coustan, 2007, Pharmacological management of gestational diabetes: an overview, S206
- American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122–1131
Cited by
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12802 · Cited by 1,238
Gestational diabetes mellitus: mechanisms, treatment, and complications
Johns, E. C., Denison, F. C., Norman, J. E., & Reynolds, R. M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.09.004 · Cited by 828
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-11-24
- Volume
- 41
- Issue
- Supplement_1
- Pages
- S137-S143
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4231599642
- Cited by
- 332
- References
- 63
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 16 · 2023: 26 · 2022: 43 · 2021: 48 · 2020: 49 · 2019: 78 · 2018: 45
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- diabetes in pregnancy, glycemic control, clinical guidelines, quality of care, treatment goals, gestational diabetes mellitus
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Pregnancy, Pregnancy in Diabetics, Diabetes, Gestational, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.